Cargando…
Tofacitinib
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585773/ https://www.ncbi.nlm.nih.gov/pubmed/21171673 http://dx.doi.org/10.2165/11588080-000000000-00000 |
| _version_ | 1782261203176783872 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3585773 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35857732013-03-07 Tofacitinib Drugs R D Adis R&D Profile Springer International Publishing 2012-11-25 2010-11 /pmc/articles/PMC3585773/ /pubmed/21171673 http://dx.doi.org/10.2165/11588080-000000000-00000 Text en © Adis Data Information BV 2010 https://creativecommons.org/licenses/by-nc-nd/3.0/This drug profile has been extracted from Wolters Kluwer’s Adis™ R&D Insight drug pipeline database. R&D Insight tracks and evaluates drug development worldwide through the entire development process, from discovery, through pre-clinical and clinical studies to market launch. This is an open access article published under the terms of the Creative Commons License “Attribution-NonCommercial-NoDerivative 3.0” (http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) ) which permits non-commercial use, distribution, and reproduction, provided the original work is properly cited and not altered. |
| spellingShingle | Adis R&D Profile Tofacitinib |
| title | Tofacitinib |
| title_full | Tofacitinib |
| title_fullStr | Tofacitinib |
| title_full_unstemmed | Tofacitinib |
| title_short | Tofacitinib |
| title_sort | tofacitinib |
| topic | Adis R&D Profile |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585773/ https://www.ncbi.nlm.nih.gov/pubmed/21171673 http://dx.doi.org/10.2165/11588080-000000000-00000 |
| work_keys_str_mv | AT tofacitinib |